Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2007 | 03-2006 | |
| Operating Expenses | 66,078 | 28,425 | 0 | 0 | 0 |
| Operating Income | -66,078 | -28,425 | N/A | N/A | N/A |
| Interest Expense | 625 | 0 | 0 | 0 | 0 |
| Other Income | 412 | -155 | 0 | 0 | 0 |
| Pre-tax Income | -66,291 | -28,580 | 0 | 0 | 0 |
| Income Tax | 97 | 19 | N/A | N/A | N/A |
| Net Income Continuous | -66,388 | -28,599 | N/A | N/A | N/A |
| Net Income | $-66,388 | $-28,599 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -1.54 | -1.29 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -1.54 | -1.29 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.54 | -1.29 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -1.54 | -1.29 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.54 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-66,057 | $-28,415 | $N/A | $N/A | $N/A |